Spectral Medical Inc. (TSE:EDT – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday. The stock traded as low as C$0.98 and last traded at C$1.01, with a volume of 16,918 shares traded. The stock had previously closed at C$1.00.
Spectral Medical Trading Down 8.3%
The company has a market cap of C$258.33 million, a PE ratio of -7.33 and a beta of 0.93. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The stock has a 50 day moving average price of C$1.19 and a 200 day moving average price of C$1.32.
Spectral Medical Company Profile
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin¿ (‘PMX’). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s FDA cleared Endotoxin Activity Assay (EAA¿), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe, licensed by Health Canada, and has been used safely and effectively with over 360,000 units sold worldwide to date.
Further Reading
- Five stocks we like better than Spectral Medical
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
